GLP-1 medicine improves liver health independent of weight loss, study finds

Researchers at Toronto’s Sinai Health have found that semaglutide—the active ingredient in popular weight loss drugs that mimic the gut hormone GLP-1—acts directly on a subset of liver cells to improve organ function and does so independently of weight loss. The finding challenges long-held assumptions about how GLP-1 medicines work in the liver and could reshape how physicians treat metabolic liver disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup